ID: MRFR/LS/1799-HCR | 80 Pages | Author: Rahul Gotadki | June 2023
Market Scenario:
The Pharmaceutical Filtration Devices Market is projected to reach USD 30,217 Million by 2030 at 18.2% CAGR during the forecast period 2022-2030.Filtration in pharmaceutical has been used to purify or separate the component and also to maintain the sterile conditions during the process to prevent contamination. Various methods are being used for filtration depends on the component that need to be filtered. Major factors such as increasing growth of pharmaceutical industry and rapid growth in the generic drug production are the main reasons driving the pharmaceutical filtration devices market growth. On the other hand the huge capital required to set up new production facilities and stringent government regulations to legalize the filtration process are expected to limit market growth to a certain extent.
Study Objectives of Pharmaceutical filtration Devices Market:
Intended Audience:
Segments: The pharmaceutical filtration devices market has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the pharmaceutical filtration devices has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly on the basis of product, the pharmaceutical filtration devices has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the pharmaceutical filtration devices has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.
Regional Analysis of Pharmaceutical filtration devices Market: Considering the global scenario of the pharmaceutical filtration devices market, Americas region is believed to be the largest market for Pharmaceutical filtration techniques and devices. Moreover the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the pharmaceutical filtration devices segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.
Key Players for Pharmaceutical filtration devices Market: Some of the key players in pharmaceutical filtration devices market are: GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), Merck KGaA (Germany), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).
The report for Pharmaceutical Filtration Devices Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current pharmaceutical filtration devices market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the pharmaceutical filtration devices market. The report provides details information and strategies of the top key players in the industry. The pharmaceutical filtration devices market report also gives a broad study of the different markets segments and regions
Report Attribute/Metric | Details |
---|---|
Market Size | USD 30,217 Million |
CAGR | 18.2% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Product, Applications, |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), Merck KGaA (Germany), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany). |
Key Market Opportunities | New product launches and R&D Amongst major key Players |
Key Market Drivers |
|
The valuation of the Pharmaceutical Filtration Devices Market is estimated to increase to USD 30,217 Million by the end of 2030.
Increasing growth of pharmaceutical industry and rapid growth in the generic drug production are major drivers of the Pharmaceutical Filtration Devices Market.
North America holds the largest share in the Pharmaceutical Filtration Devices Market, followed by Europe and the Asia Pacific, respectively.
Pall Corporation (U.S.), GE Healthcare (U.S.), Parker Hannifin Corporation (U.S.), Merck KGaA (Germany), Sartorius Stedim Biotech S.A. (France), Alfa Laval (Sweden), Koch Membrane Systems Inc. (U.S.), Graver Technologies, LLC (U.S.), and GEA Group (Germany), are some of the major players operating in the pharmaceutical filtration devices market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global pharmaceutical filtration devices market adopt to gain a larger competitive advantage.
Key Questions Answered
Why Choose Market Research Future?